Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Y. V. Lukina"'
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 1, Pp 99-104 (2021)
The new coronavirus infection (COVID-19) pandemic and the subsequent quarantine measures, particularly home isolation of the population, could have seriously affected the quality of pharmacotherapy and adherence to it by patients with chronic non-com
Externí odkaz:
https://doaj.org/article/c2eb69d9dab24d1fb58913d8f22cb541
Autor:
S. Yu. Martsevich, Y. V. Lukina
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 13, Iss 5, Pp 699-705 (2017)
Oral anticoagulant (OAC) therapy is currently gaining special importance due to the significant spread of atrial fibrillation (AF) in the population (especially in older age groups). The use of OAC in AF has an extensive evidence base, which confirms
Externí odkaz:
https://doaj.org/article/1cee1c3b640646aa8fd23721aea923d6
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 5, Iss 2, Pp 98-102 (2016)
Problems of educational programs for patients with cardio-vascular diseases in schools of health are discussed. Comparison of andragogic (adult education) and pedagogic education models are analyzed. The pedagogic education model is currently dominat
Externí odkaz:
https://doaj.org/article/309225f912f34d478c5f839c7f35ff81
Autor:
M. A. Maksimova, Y. V. Lukina, S. N. Tolpygina, E. V. Shilova, N. A. Dmitrieva, S. Y. Martsevich
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 4, Iss 2, Pp 34-37 (2016)
Aim. To evaluate efficacy and safety of a new drug of amlodipine – S-amlodipine (Azomex, Emcur, India) compared to original drug of racemic amlodipine (Norvasc, Pfizer, USA) in patients with arterial hypertension (HT) of I-II grade.Material and met
Externí odkaz:
https://doaj.org/article/dcc51834abe74f69978ef3928276aee6
Autor:
N. P. Kutishenko, N. A. Dmitrieva, Y. V. Lukina, M. P. Kozireva, Y. E. Semyonova, A. D. Deev, S. Y. Martsevich
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 1, Iss 2, Pp 37-42 (2015)
Aim. To study influence of mildronate (M) on treatment efficiency of patients with ischemic heart disease (IHD), receiving standard antianginal therapy (AAT)Materials and methods. Double-blind, randomized, placebo-controlled study was carried out in
Externí odkaz:
https://doaj.org/article/fecfb98b9aef468eb6fa669ebd156a00
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 10, Iss 3, Pp 288-292 (2015)
Aim. To evaluate the frequency of the prescription of cardiovascular drugs in patients before the reference acute myocardial infarction (AMI) based on the register "LIS-1" (Lubertsy mortality study of patients after myocardial infarction).Material an
Externí odkaz:
https://doaj.org/article/02bc092143ec47cfad4942d987449a76
Publikováno v:
The Open Cardiovascular Medicine Journal. 15:52-55
Takotsubo syndrome is a type of acute reversible heart failure that can involve a form of acute catecholaminergic myocardial stunning. This clinical entity shows a pattern of temporary left ventricular dysfunction in the absence of occlusion of any c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0b9a0e64cef7f5c7d0566812986f6f7
https://doi.org/10.2174/1874192402115010052
https://doi.org/10.2174/1874192402115010052
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 17, Iss 1, Pp 99-104 (2021)
The new coronavirus infection (COVID-19) pandemic and the subsequent quarantine measures, particularly home isolation of the population, could have seriously affected the quality of pharmacotherapy and adherence to it by patients with chronic non-com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad9618157470655ccd2ce34192198e8f
https://www.rpcardio.com/jour/article/view/2393
https://www.rpcardio.com/jour/article/view/2393
Publikováno v:
Revista Portuguesa de Cardiologia, Vol 34, Iss 2, Pp 111-116 (2015)
Revista Portuguesa de Cardiologia (English Edition), Vol 34, Iss 2, Pp 111-116 (2015)
Revista Portuguesa de Cardiologia (English Edition), Vol 34, Iss 2, Pp 111-116 (2015)
Objective: The aim of this study was to analyze the quality of lipid-lowering therapy in a cohort of patients with cardiovascular disease enrolled in a Moscow-based registry, and to analyze the factors affecting the regularity of statin administratio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29900dedfb1a2b1ff98f3172781bd5f3
https://doi.org/10.1016/j.repc.2014.08.021
https://doi.org/10.1016/j.repc.2014.08.021
Publikováno v:
Obesity Medicine. 15:100119
Aim Assessment of treatment specifics in patients with obesity and patients' adherence to doctors’ recommendations within the outpatient registry PROFILE. Methods The registry PROFILE included patients with chronic cardiovascular diseases (CVD) or/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3d7aa084156218a853ff9a5157f816c
https://doi.org/10.1016/j.obmed.2019.100119
https://doi.org/10.1016/j.obmed.2019.100119